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1. Introduction 
The human eye is a complex organ of vital importance for everyday life. Eyes are the parts of 
our body that perceive light to see the world and to understand how objects relate to each 
other. We can distinguish far objects from close ones and determine their color and shape 
(Figure 1). The cornea is the dome-shaped window in the front of the eye. When looking at a 
person's eye, one can see the iris and pupil through the normally clear cornea. The cornea 
bends light rays as a result of its curved shape and accounts for approximately two-thirds of 
the eye's total optical power, with the lens of the eye contributing the remaining one-third. The 
cornea is as smooth and clear as glass but is strong and durable (Figure 2). It helps to shield the 
rest of the eye from germs, dust, and other harmful matter. The cornea shares this protective 
task with the eyelids, the eye socket, tears, and the sclera, or white part of the eye. A very thin 
tear film lies between the front of the cornea and our environment. The cornea copes very well 
with minor injuries or abrasions. If the highly sensitive cornea is scratched, healthy cells slide 
over quickly and patch the injury before infection occurs and vision is affected. 
 
Fig. 1. Structure of the eye                                                  
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Fig. 2. Cornea is the clear part of the eye that covers the pupil 
Bacterial keratitis is an infection and inflammation of the cornea that cause pain, reduced 
vision, light sensitivity and tearing or discharge from the eye that can, in severe cases 
cause loss of vision. Bacterial keratitis progresses rapidly and corneal destruction may be 
complete in 24 - 48 hours with some of the more virulent bacteria. The severity of the 
corneal infection usually depends on the underlying condition of the cornea and the 
pathogenicity of the infecting bacteria. It may involve the center of the cornea or the 
peripheral part of the cornea (that portion closest to the sclera) or both. Keratitis may 
affect one eye or both eyes. Keratitis may be mild, moderate, or severe and may be 
associated with inflammation of other parts of the eye (Figure 3). Keratitis can be 
classified by its location, severity, and cause. If keratitis involves the surface (epithelial) 
layer of the cornea, it is called superficial keratitis.  Kerato-conjunctivitis is inflammation 
of the cornea and the conjunctiva. Kerato-uveitis is inflammation of the cornea and the 
uveal tract, which consists of the iris, ciliary body, and choroid. Keratitis may be acute or 
chronic. It may occur only once or twice in an eye or be recurrent. It may be limited in its 
effects on the eye or be progressive in its damage. Bacterial keratitis is a sight-threatening 
process. Many patients have a poor clinical outcome if aggressive and appropriate 
therapy is not promptly initiated. Some cases of keratitis results from unknown factors. 
Until recently, most cases of bacterial keratitis were associated with ocular trauma or 
ocular surface diseases. Various types of infections, dry eyes, injury, and a large variety of 
underlying medical diseases may all lead to keratitis. 
Dry eye syndrome (DES; keratoconjunctivitis sicca) is a disorder of the tear film due to tear 
deficiency or excessive evaporation, which cause damage to the ocular surface. (Holly et al., 1977; 
Janumala H et al., 2009, 2010; Lemp et al., 1998; Tsubota et al, 1996) The signs of DES include foreign body 
sensation, ocular discomfort (scratchy, dry, sore, gritty, burning sensations) and problems 
with visual acuity. (Stern et al., 1998; Tsubota et al., 1992) Bacterial keratitis accounts for approximately 65% 
to 90% of all corneal infections. (Marios et al., 2007) 
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Fig. 3. Human eye with non-ulcerative Bacterial Keratitis 
The spectrum of bacterial keratitis can also be influenced by geographic and climatic factors. 
Many differences in keratitis profile have been noted between populations living in rural or 
in city areas, in western, or in developing countries. Ulcerations of the cornea may occur, a 
condition known as ulcerative keratitis. Before the advent of antibiotics, syphilis was a 
frequent cause of keratitis. Corneal ulceration, stromal abscess formation, surrounding 
corneal edema, and anterior segment inflammation are characteristic of this disease. There 
are several types of keratitis, including superficial punctate keratitis, in which the cells on 
the surface of the cornea die; interstitial keratitis, a condition that can be either the direct 
result of infection, or more commonly secondary to an immunologic process; herpes simplex 
viral keratitis, caused by the sexually transmitted herpes virus; and traumatic keratitis, 
which results when a corneal injury leaves scar tissue. Early diagnosis and treatment is the 
key to minimizing any visual-threatening sequelae. In addition, close follow-up, attention to 
laboratory data, and changing antimicrobials if no clinical improvement is evident are 
important elements for successful outcome. The severity of the corneal infection usually 
depends on the underlying condition of the cornea and the pathogenicity of the infecting 
bacteria. Many patients have a poor clinical outcome if aggressive and appropriate therapy 
is not promptly initiated. (Acharya et al., 2009; Tang et al., 2009) 
1.1 Epidemiology frequency 
The most common predisposing factor for keratitis in southeast Brazil is trauma, especially 
corneal injury due to vegetation; observation clearly connected with following risk factors. 
The risk of agricultural predominance and vegetative corneal injury in fungal keratitis and 
associated ocular diseases in bacterial keratitis increase susceptibility to corneal infection. A 
hot, windy climate makes fungal keratitis more frequent in tropical zones, whereas bacterial 
keratitis is independent of seasonal variation and frequent in temperate zones. In tropical 
countries the incidence of bacterial keratitis is pathogens and show geographical variation in 
their prevalence. Thus, the spectrum of microbial keratitis varies with geographical location 
influenced by the local climate and occupational risk factors. In United States 
Approximately 25,000 Americans develop bacterial keratitis annually. International 
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incidence of bacterial keratitis varies considerably, with less industrialized countries having 
a significantly lower number of contact lens users and, therefore, significantly fewer contact 
lens-related infections. Mortality/Morbidity in cases of severe inflammation, a deep ulcer 
and a stromal abscess may coalesce, resulting in thinning of the cornea and sloughing of the 
infected stroma.  
2. Causes of bacterial keratitis 
Keratitis can lead to vision loss from corneal scarring. Physical or chemical trauma is a 
frequent cause of keratitis. If the cornea is hit and damaged by a foreign body (a finger nail, 
an arm, a metal splinter or through contact lenses), can cause a scratch to the cornea. 
Scratches are usually harmless and not very deep, but they give bacteria and viruses the 
possibility of attacks, which gives the cornea inflammation and should therefore be detected 
and treated. There are various types of keratitis, but most commonly it occurs after an injury 
to the cornea, dryness, inflammation of the ocular surface or contact lens wear. A wide 
variety of conditions can lead to inflammation of the cornea. Among them are viral, 
bacterial, or fungal infections; exposure to ultraviolet light such as sunlight or sunlamps; 
exposure to other intense light sources such as welding arcs or snow or water reflections; 
irritation from excessive use of contact lenses; dry eyes caused by an eyelid disorder or 
insufficient tear formation; a foreign object in the eye; a vitamin A deficiency; or a reaction 
to eye drops, eye cosmetics, pollution, or airborne particles such as dust, pollen, mold, or 
yeast. The condition is also a side effect of certain medications. Bacterial keratitis remains 
one of the most important potential complications of contact lens use and refractive corneal 
surgery. "Organisms can infiltrate an intact cornea of a lens-wearer, and a biofilm can form 
on the contact lens. Interruption of an intact corneal epithelium and/or abnormal tear film 
permits entrance of microorganisms into the corneal stroma, where they may proliferate and 
cause ulceration or secondary effect or molecules and cause infection. The epithelium and 
stroma in the area of injury and infection swell and undergo necrosis. Acute inflammatory 
cells (mainly neutrophils) surround the beginning ulcer and cause necrosis of the stromal 
lamellae. The collagen of the corneal stroma is poorly tolerant of the bacterial and leukocytic 
enzymes, and undergoes degradation, necrosis and thinning. This leads to scarring of the 
cornea. As thinning advances, the cornea may perforate, thus introducing bacteria into the eye 
with ensuing endophthalmitis. Corneal infections rarely occur in the normal eye. They are a 
result of an alteration in the cornea’s defense mechanisms that allow bacteria to invade when 
an epithelial defect is present. The organisms may come from the tear film or as a contaminant 
from foreign bodies, contact lenses or irrigating solutions. The severity of the disease depends 
on the strain of the organism, the size of the inoculums, the susceptibility of the host and 
immune response, the antecedent therapy and the duration of the infection. The process of 
corneal destruction can take place rapidly (within 24hrs with virulent organisms) so that rapid 
recognition and initiation of treatment is imperative to prevent visual loss.  
Contact lens users are at an increased risk of corneal ulcers (Figure 4, Figure 5). The annual 
incidence of bacterial keratitis with daily-wear lenses is 3 cases per 10,000. Contact lens is the 
leading cause of corneal inflammation, and if we as a contact lens user experience the following 
symptoms should seek medical attention right away. The injury may become secondarily 
infected or remain noninfectious. Retained corneal foreign bodies are frequent sources of 
keratitis. (Dart et al., 1988; Liesegang et al 1997; Moriyama et al., 2008; Musch et al 1983; Poggio et al., 1989; Weissman et al., 2002) 
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Fig. 4. Contact lens use      
   
Fig. 5. Eye with keratitis infection due to contact lens use  
2.1 Other causes for bacterial keratitis are 
• Disturbances in the tear film may lead to changes in the corneal surface through drying 
of the corneal epithelium. This type of keratitis is usually superficial and most 
commonly is related to dry eyes and is known as keratitis sicca. If the eyes are 
extremely dry, the surface cells may die and form attached filaments on the corneal 
surface, a condition known as filamentary keratitis. 
• Disorders that cause dry eyes; has no or limited germ fighting protection tears causing 
ulcers. 
• Chemical solution splashes can injure the cornea and lead to corneal ulceration. 
Ultraviolet light from sunlight (snow blindness), a tanning light or a welder's arc, contact-
lens over wear, and chemical agents, either in liquid form splashed into the eye or in gases 
in the form of fumes can all result in non-infectious superficial punctate keratitis, 
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• Inability to close the eyelids properly can also lead to cornea drying, including 
entropion with trichiasis and lagophthalmos a condition termed exposure keratitis. 
• Allergies to airborne pollens or bacterial toxins in the tears may also cause a non-
infectious type of keratitis. Autoimmune diseases create a similar appearance, often 
affecting the periphery of the cornea, termed marginal keratitis or limbic keratitis. 
• Decreased immunologic defenses secondary to malnutrition, alcoholism, and diabetes 
(Moraxella). 
Corneal ulcers are commonly caused by bacterial or fungal invasions following superficial 
corneal abrasions; among the common infectious agents are: staphyloccus, streptococcus, 
herpes (both simplex and zoster), adenovirus, rubeola, rubella, mumps, trachoma, infectious 
mononucleosis, and pneumococcus; also at fault may be Vitamin A deficiency or broad - 
spectrum antibiotic drug reactions. Corneal ulcers may also follow trauma, may be 
associated with other eye infections (e.g., conjunctivitis), may be related to other corneal 
disorders (e.g., degenerative conditions, or ptosis, which may cause a "dry eye"), or may 
arise from a variety of systemic disorders (especially those of autoimmune origin). In cases 
of severe inflammation, a deep ulcer and a stromal abscess may coalesce, resulting in 
thinning of the cornea and sloughing of the infected stroma. Once the corneal defenses are 
breached, specifically the epithelial glycocalyx, the cornea is prone to infection. Possible 
causes include direct corneal trauma, chronic eyelid disease, tear film abnormalities 
affecting the ocular surface and hypoxic trauma from contact lens wear. Pathogenic bacteria 
colonize the corneal stroma and immediately become antigenic, both directly and indirectly, 
by releasing enzymes and toxins. This sets up an antigen-antibody immune reaction that 
leads to an inflammatory reaction. The body releases polymorphonuclear leukocytes 
(PMNs) that aggregate at the area of infection, creating an infiltrate. The PMNs phagocytize 
and digest the bacteria. The collagen stroma is poorly tolerant of the bacterial and leukocytic 
enzymes and undergoes degradation, necrosis and thinning. This results in scarring of the 
cornea. With severe thinning the cornea may perforate, creating the possibility for 
endophthalmitis.  
2.2 Gender 
Males have a 30 to 40 per cent increased risk of developing keratitis compared to females. 
This gender difference has been reported previously for microbial keratitis. The reason for 
this association may be related to perceived health risks. Males have different attitudes and 
perceptions relating to health risks than do females, whereby they perceive risks as much 
smaller and much more acceptable. For example, males may be more inclined to 
underestimate the risk of developing corneal infiltrative events (CIE) when sleeping in 
contact lenses. (Efron et al., 2005a, 2005b, 2006; Morgan et al., 2005a, 2005b) 
2.3 Smoking 
Smoking was found to be associated with a 35 per cent greater risk of developing CIE’s and 
this was increased to two-fold for severe keratitis. Others have reported similar findings. 
Smoking may be a risk factor for a number of reasons. It is generally considered that 
smoking is an unhygienic pursuit, which may be linked to a general lack of hygiene with 
respect to matters relating to contact lens wear and care. Toxins from smoke may either 
irritate the eyes directly or become absorbed into the contact lens and act as an irritant that 
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compromises the health of the ocular surface and predisposes the eye to the development of 
corneal infiltrative events (CIE). Cigarette smoke is known to have an immuno-modulatory 
effect, which may indirectly predispose a cigarette smoker to develop a CIE. 
2.4 Ocular and general health 
Lens wearers have approximately twice the risk of developing a CIE in the absence of 
compromised ocular and general health. The protective effect of compromised ocular health 
in lowering the risk of contact lens associated CIEs may be explained by the precautionary 
attitude adopted by those with compromised ocular health in that such persons may cease 
lens wear, reduce wearing time or use self-prescribed topical ocular medications in an 
attempt to alleviate their condition. Such strategies might have the secondary effect of 
precluding the development of a CIE. An alternative explanation is that compromised 
ocular health may be associated with a general up- regulation of the innate defense status of 
the eye, so that there is an ever-present resistance to extraneous challenges to the ocular 
surface, which could result in a CIE. These principles can be extended to explain why 
compromised general health also serves to protect the eye from developing a CIE.   
2.5 Season 
The notion that adverse ocular conditions related to contact lens wear can be influenced by the 
time of year (seasonal effect) is well established; for example, Begley, Riggle and Tuel reported 
that the onset of contact lens-associated papillary conjunctivitis was seasonal, in that the 
incidence of this condition peaked during the allergy seasons in mid-western USA. We found 
a two to four times increased risk of developing CIEs in late winter (January to March in the 
northern hemisphere) compared with mid-summer (July in the northern hemisphere). We 
accessed the number of consultations for influenza-like illness to the United Kingdom 
National Health Service helpline by people aged 15 to 64 years in England during the same 
period as the Manchester Keratitis Study. This number peaked around October and November 
2003, which is in disacordance with the peak incidence of CIEs in our study from January to 
March 2003. Interestingly, this observation is consistent with the finding of a lower incidence 
of CIEs in association with compromised general health. (Efron et al. 2006) 
2.6 Risk of keratitis 
In the Manchester Keratitis Study (Morgan et al 2005), logistic regression analyses were performed 
to investigate the association between a range of risk factors and the occurrence of CIEs. 
Daily wear of rigid lenses was found to be associated with a lower risk of developing CIEs 
compared with daily wear of hydrogel lenses. The risk of developing CIEs when sleeping in 
contact lenses is higher than in daily lens wear.  
3. Symptoms of bacterial keratitis 
The symptoms of keratitis usually include pain, tearing, and blurring of vision. The pain 
may be mild to severe, depending on the cause and extent of the inflammation. Sensitivity 
to light may also be present. To the observer, the eye may appear red, watery, and if the 
cornea has extensive keratitis, the normally clear cornea may look grey or have white to 
grey areas.  
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3.1 Physical 
External and biomicroscopic examination of these patients reveal some or all of the 
following features: Ulceration of the epithelium; corneal infiltrate with no significant tissue 
loss; dense, suppurative stromal inflammation with indistinct edges; stromal tissue loss; and 
surrounding stromal edema. Increased anterior chamber reaction with or without hypopyon 
folds in the descemet membrane. Upper eyelid edema, Posterior synechiae surrounding 
corneal inflammation is either focal or diffuse, conjunctival hyperemia adherent 
mucopurulent exudate, endothelial inflammatory plaque. 
A scratch on the cornea can cause 
• Light annoyance. 
• Blurred vision. 
• Feeling "something in the eye". 
• Pain 
Cornea inflammation with bacteria cause 
• Your eye turns red. 
• Pain, impaired vision and sensitivity to light as a scratch. 
• May be you see a gray-white speck in the eye (the pupil). 
The patient will present with a unilateral, acutely painful, photophobic, eye. Visual acuity is 
usually reduced, and profuse tearing is common. There will be a focal stromal infiltrate with 
an overlying area of epithelial excavation. There is likely to be thick, ropy, mucopurulent 
discharge. The cornea will be very edematous. The conjunctival and episcleral vessels will 
be deeply engorged and inflamed, often greatly out of proportion to the size of the corneal 
defect. In severe cases, there will be a pronounced anterior chamber reaction, often with 
hypopyon. Intraocular pressure may be low due to secretory hypotony of the ciliary body, 
but most often will be elevated due to blockage of the trabecular meshwork by 
inflammatory cells. Often, the eyelids will also be edematous. Bacterial keratitis is a sight-
threatening process. Bacterial keratitis makes the cornea cloudy. It may also cause abscesses 
to develop in the stroma, which is located beneath the outer layer of the cornea. 
Interruption of an intact corneal epithelium and/or abnormal tear film permits entrance of 
microorganisms into the corneal stroma, where they may proliferate and cause ulceration. 
Virulence factors may initiate microbial invasion, or secondary effector molecules may assist 
the infective process. Many bacteria display several adhesions on fimbriated and non-
fimbriated structures that may aid in their adherence to host corneal cells. During the initial 
stages, the epithelium and stroma in the area of injury and infection swell and undergo 
necrosis. Acute inflammatory cells (mainly neutrophils) surround the beginning ulcer and 
cause necrosis of the stromal lamellae. Diffusion of inflammatory products (including 
cytokines) posteriorly elicits an outpouring of inflammatory cells into the anterior chamber 
and may create a hypopyon. Different bacterial toxins and enzymes (including elastase and 
alkaline protease) may be produced during corneal infection, contributing to the destruction 
of corneal substance. The most common groups of bacteria responsible for bacterial keratitis 
are as follows: Streptococcus, Pseudomonas, Enterobacteriaceae (including Klebsiella, Enterobacter, 
Serratia, and Proteus), and Staphylococcus species.  
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3.2 Complications with keratitis  
Irregular astigmatism: Another possible complication of these infections is uneven healing 
of the stroma, resulting in irregular astigmatism.  
Corneal perforation: This is one of the most feared complications of bacterial keratitis that 
may result in secondary endophthalmitis and possible loss of the eye.  
3.3 How is keratitis diagnosed? 
Keratitis can be diagnosed by an ophthalmologist (a physician who specializes in diseases 
and surgery of the eye) by physical examination of the eye and history. The history consists 
of questions documenting a past medical and ocular history and the symptoms specific to 
the current visit. The eye examination will consist of checking the vision and careful 
inspection of the corneas using a slit lamp, which is a microscope with excellent illumination 
and magnification to view the ocular surface and the cornea in detail. In cases in which 
infection is suspected, a culture may be taken from the surface of the eye for specific 
identification of the bacteria, virus, fungus, or parasites causing keratitis. Slit lamp 
examination helps to diagnose the depth of the keratitis eye infection. 
• Swab the eye or take samples from the eye to confirm the diagnosis of herpes simplex 
infection. 
• Testing visual sharpness and clearness (visual acuity). 
• Testing how well the pupil responds to light. 
• Patients’ history to know about any recent infection of the upper respiratory tract 
accompanied by cold sores. 
• Blood tests may also be done in certain patients with suspected underlying disease.  
3.4 What are the risk factors for keratitis? 
• Major risk factors for the development of keratitis include any break or disruption of 
the surface layer (epithelium) of the cornea.  
• The use of contact lenses increases the risk for the development of keratitis, especially in 
poor hygiene, improper solutions, or over wear of the lens. 
• A decrease in the quality or quantity of tears predisposes the eye to the development of 
keratitis due to corneal drying.  
• Disturbances of immune function through diseases such as AIDS or the use of 
medications such as corticosteroids or chemotherapy also increase the risk of 
developing keratitis.   
3.5 Precautions and complications of corneal inflammation 
If you have a job where you are exposed to metal pieces or similar things, you should wear 
goggles and visit a doctor when symptoms of a scratch on the cornea appear to prevent 
inflammation. Inflammation can spread deeper into the cornea and is difficult to treat. 
Therefore we should seek medical advice by herpes cornea inflammation every time. 
Bacteria can also produce a severe corneal inflammation, which in the worst case, 
permanent visual impairment. You must also not wear contact lenses before the eye has 
healed. If the scratch penetrates the cornea more deeply, however, the healing process will 
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take longer, at times resulting in greater pain, blurred vision, tearing, redness, and extreme 
sensitivity to light. These symptoms require professional treatment. Deeper scratches can 
also cause corneal scarring, resulting in a haze on the cornea that can greatly impair vision. 
In this case, a corneal transplant may be needed. 
4. Treatment of bacterial keratitis 
Wound healing of the ocular surface is a special process due to its non-vascularity. It 
depends on surrounding corneal tissues for nourishment. Healing requires regeneration of 
the corneal and conjunctival epithelium, reduced scar formation, retention of transparency 
of cornea and mobility of the conjunctiva. Janumala H et al., 2009; Reim et al. 1997) The process of corneal 
wound healing consists of different phases, i.e. latent phase, cell migration, adhesion and 
cell proliferation. Another fluoroquinolone, ofloxacin 0.3% (Ocuflox) is also an effective 
treatment for bacterial keratitis. Both fluoroquinolones are as effective at managing bacterial 
keratitis as fortified antibiotics, but with significantly fewer side effects. (Marios et al., 2007; Baker et 
al., 1996) Adjunctive use of cold compresses will also help to reduce inflammation. If there is 
evidence of secondary inflammatory glaucoma, Rx a topical beta-blocker BID. Have the 
patient return daily for follow-up visits. Once the infection is controlled, add a topical 
steroid Q2H to the regimen. Continue the daily follow-up and begin to taper all medications 
as you see improvement. (McLeod et al., 1995) 
4.1 What is the treatment for keratitis? 
Medical treatment is absolutely essential - even a delay of a few hours can affect the ultimate 
visual result. The causative factors must be determined through laboratory analysis of 
scrapings; medical treatment (i.e., medication) varies according to the cause. As with 
bacterial conjunctivitis, culturing the infection is the ideal way to determine the infecting 
organism but is often difficult or impractical. First and foremost, you must halt bacterial 
proliferation; do not delay treatment while waiting for the culture results. If you have the 
materials available, scrape the ulcer using a platinum spatula and plate the specimen into 
blood and chocolate agar culture media. A simpler but less effective method is to use a 
culturette. (McLeod et al 1996; Miedziak et al., 1999; Schaefer et al., 2001) Regardless, immediately begin therapy 
with a broad - spectrum antibiotic. A popular initial therapy is the fluoroquinolone 
ciprofloxacin 0.3% (Ciloxan) two drops every 15 minutes for six hours, followed by two 
drops every 30 minutes for 18 hours, and then tapered depending on patient response. 
Infectious keratitis generally requires antibacterial therapy to treat the infection. This 
treatment can involve prescription eye drops, pills, or even intravenous therapy. Any 
corneal or conjunctival foreign body should be removed. Wetting drops may be used if 
disturbance of the tears is suspected to be the cause of the keratitis. Steroid drops may often 
be prescribed to reduce inflammation and limit scarring. This must be done carefully and 
judiciously, since some infections can be worsened with their use. Treatment depends 
largely on the source of the problem. If a common adenoviral virus is causing the keratitis, 
the condition is likely to clear up on its own, usually in about two to three weeks. Available 
medications for this form of keratitis include palliative treatment. Contact-lens wearers are 
typically advised to discontinue contact-lens wear, whether or not the lenses are related to 
the cause of the keratitis.  
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4.2 Treatment of scratches on the cornea 
• Foreign body should be removed if it sits in the eye. 
• Antibiotics-drops to prevent inflammation. 
• Possibly putting a small bandage over the eye in order to give it a little calm. 
4.3 Keratitis antibiotic treatment 
Staphylococcus aureus is a major cause of bacterial keratitis. (Alexandrakis et al., 2003; Liesegang et al. 1998)  
S. aureus ocular infections can cause severe inflammation, pain, corneal perforation, scarring, 
and loss of visual acuity. (Chusid et al., 1979)  S. aureus has a long history of evolving to more resistant 
states, and this trend is expected to continue. (Hiramatsu et al., 1997; Peterson, 1999) Therefore, new 
antibiotics and new antibiotic formulations are needed to manage future cases of S. aureus-
induced keratitis. Moxifloxacin and gatifloxacin are “fourth generation” fluoroquinolone 
antibiotics that target bacterial DNA gyrase (topoisomerase II) and topoisomerase IV. (Adams et al., 
1992; Dalhoff et al., 1996; Kato et al., 1992; Shen, 1994) These fourth generation fluoroquinolones have in vitro 
activity similar to that of ciprofloxacin and ofloxacin (extended-spectrum fluoroquinolones) 
against gram-negative bacteria but enhanced activity against gram-positive bacteria, including 
S. aureus. (Biedenbach et al., 1996; Davis et al. 1994) A broadspectrum antibiotic may prevent secondary 
bacterial infection. Chronic dendritic keratitis may be effectively treated with vidarabine, long 
term topical therapy may be necessary. Keratitis due to exposure requires application of 
moisturizing ointment to the exposed cornea and protects it with eye patch. Severe corneal 
scarring may be treated by keratoplasty (cornea transplantation). Slit lamp photography can be 
useful to document the progression of the keratitis, A B-scan ultrasound can also be carried out 
in severe corneal ulcers with no view of the posterior segment. The fourth-generation 
ophthalmic fluoroquinolones include moxifloxacin and gatifloxacin and they are now being 
used for the treatment of bacterial conjunctivitis. Both antibiotics have better in vitro activity 
against gram-positive bacteria than ciprofloxacin or ofloxacin. Moxifloxacin penetrates better 
into ocular tissues than gatifloxacin and older fluoroquinolones; in vitro activity of moxifloxacin 
and gatifloxacin against gram-negative bacteria is similar to that of older fluoroquinolones. 
Polymicrobial keratitis has been reported in up to 12% of cases and can be difficult to treat. The 
use of multiple antibiotics simultaneously and with frequent dosing may result in added 
toxicity and damage to the ocular surface epithelium, thereby impairing recovery. 
Demonstration of broad-spectrum efficacy, excellent safety profiles in ocular infections, and a 
distinct mode of resistance acquisition. Moxifloxacin is a fourth-generation fluoroquinolone that 
exhibits a broad spectrum of bactericidal activity against both Gram-positive and Gram - 
negative bacterial pathogens, including staphylococci, S. pneumoniae, members of the family 
enterobacteriaceae, P. aeruginosa, H. influenzae, and Moraxella species. Moxifloxacin also has 
better mutant prevention characteristics than other fluoroquinolones. Moxifloxacin has also 
been shown to have superior activity compared with ciprofloxacin against quinolone resistant 
strains of S. aureus. Data also shows superior corneal and aqueous penetration of moxifloxacin 
(Solomon R, Donnenfeld E, et al.) Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5% and 
ciprofloxacin 0.3% into the aqueous humor.  
4.4 Treatment with Succinylated Collagen Bandage lenses (SCBL) 
Succinylated Collagen Bandage Lenses SCBL, are prepared with modified collagen (pH7.4) a 
natural biopolymer with biocompatibility with the human cornea, bioerodability, non-
immunogenicity, high oxygen permeability, good water content, optimum thickness and 
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superior physiological environment compared to hydrogel lenses. When used as a corneal 
adjunct in various conditions SCBL eliminates side effects such as irritation of the cornea, 
inflammation, watering, reduced visual acuity etc. SCBL shows promise to treat dry eyes, 
keratitis and epithelial trauma. (Janumala H et al.,2008, Janumala H et al., 2009) 
4.5 Complications of keratitis? 
Superficial keratitis involves the superficial layers of the cornea and commonly does not lead 
to scarring. More extensive keratitis involves deeper layers of the cornea, and a scar may 
develop upon healing. This will affect the vision if the central portion of the cornea is involved. 
With severe ulcerative keratitis, the cornea may perforate, which is an extremely serious 
situation. With proper diagnosis and appropriate treatment including follow-up care, keratitis 
can usually be managed without causing permanent visual disturbances. (Callegan et al., 1992; Davis et 
al. 1978) Vision often improves with treatment of the underlying infection. However, there may 
be some scarring of the cornea after treatment that may or may not affect vision in the long 
run.  If the corneal scarring is in the center of the cornea, where it affects the line of site, a 
corneal transplant may ultimately be needed to improve the vision. 
4.6 Can keratitis be prevented? 
The risk of keratitis can be reduced through the use of safety precautions to avoid eye 
injury, and the prompt treatment of early ocular symptoms.  
• Many forms of keratitis can be prevented by good hygiene. 
• Protecting the cornea from injury is the first step, since keratitis also results from a 
corneal injury. 
• If you have a cold sore or genital herpes, avoid touching the eyes. 
• Have well balanced diet, including vitamin A rich foods such as carrots, squash, 
mangoes, sweet potatoes and spinach. 
4.6.1 Prevention tips for contact lens users 
• Contact lens users should always use sterile lens cleanser and disinfection solution. 
• Do not over use contact lenses at night and make the eyes red or irritated. 
• Never sleep with the contact lenses in the eyes. 
• Always store the lenses in disinfecting solutions overnight. 
• Regularly clean your contact lens case. 
• Careful contact-lens care including proper cleaning of contact lens cases. 
4.6.2 Keratitis home remedies 
• A sterile, cotton-tipped applicator may be used to gently remove infected tissue and 
allow the eye to heal more rapidly. 
• Can wear an eye patch to protect it from bright light and foreign particles. 
• Minor infections are treated with antibacterial or antifungal eye drops. 
• If keratitis is caused by dry eye, artificial tears for lubrication are effective. 
• Vitamin supplementation such as vitamin A can be used in case deficiency is a 
suspected cause. 
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4.7 Clinical pearls  
• If a patient presents with a corneal infiltrate but no overlying epithelial staining, the 
condition is not bacterial keratitis. If there is epithelial breakdown but only minor 
inflammation and anterior chamber reaction, then it is most likely not infectious 
bacterial keratitis.  
• The inflammatory reaction is as damaging to the cornea as the infective organism. Once 
you've halted bacterial proliferation, be sure to prescribe a steroid to speed healing and 
reduce corneal scarring. For steroids to be beneficial, they must be used while the ulcer 
bed is still open, usually within the first 24 to 48 hours. If you wait until the ulcer re-
epithelializes before adding a steroid, the beneficial effects will be lost. 
5. Conclusion  
• It is extremely important to treat keratitis before corneal tissue is destroyed and scar 
tissue is formed. Because the pain is so severe in keratitis, the patient usually welcomes 
medical attention. However, if the cornea loses its sensitivity (as in trauma, surgery, or 
damage to the trigeminal nerve), ulcers can develop without accompanying pain. 
• The implications for personal hygiene are evident, especially with children. Hand 
washing during periods of illness and following toileting is of vital importance as a 
preventive measure. 
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